Cardinal Health Inc. (CAH)
Cardinal Health (CAH) Morgan Stanley 22nd Annual Global Healthcare Conference Transcript
Cardinal Health, Inc. (NYSE:CAH ) Morgan Stanley 22nd Annual Global Healthcare Conference September 5, 2024 8:30 AM ET Company Participants Matt Sims - VP, IR Aaron Alt - CFO Conference Call Participants Erin Wright – Morgan Stanley Erin Wright Hi, good morning, everyone. My name is Erin Wright.
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Greenville Center to Boost CAH Stock's at-Home Solution Business
Cardinal Health announces the opening of its new distribution center in Greenville to support its at-Home Solutions business.
Cardinal Health Q4 Earnings: FY25 Is A Short-Term Blip
Cardinal Health stock remains a buy due to strong pharmaceutical business growth and increased shareholder returns, despite short-term OptumRx and inflation challenges. Q4 and FY24 earnings exceeded expectations with revenue up 12% and gross margin up 5%, driven by pharmaceutical and medical products. DCF analysis supports a $128 price target, 17% upside, with Wall Street's average at $116; industry tailwinds bolster valuation.
Cardinal Health Soars as America's Leading Acute Care Supplier
Cardinal Health Inc. CAH is a global pharmaceutical and medical products distributor serving over 100,000 hospitals. It's also the largest distributor of medical supplies and surgical products in the United States.
Cardinal Health (CAH) to Open New Distribution Center in Ohio
Cardinal Health's (CAH) new center is set to integrate cutting-edge technology and automation, enhancing efficiency, storage capacity and quality of service.
Cardinal Health Beats Estimates, Boosts Guidance on Strong Drug Sales
Shares of Cardinal Health (CAH) gained in intraday trading Wednesday as the provider of healthcare services and products posted better-than-anticipated results and raised its outlook on strong drug sales.
Cardinal Health (CAH) Beats on Q4 Earnings, Ups '24 EPS View
Cardinal Health's (CAH) fourth-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
Cardinal Health Stock Pops on Beat-and-Raise
Cardinal Health Inc (NYSE:CAH) stock is gapping higher on the charts today, after the company announced strong fiscal fourth-quarter results and raised its full-year guidance.
Here's What Key Metrics Tell Us About Cardinal (CAH) Q4 Earnings
Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Cardinal Health (CAH) Q4 Earnings and Revenues Top Estimates
Cardinal Health (CAH) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.72 per share. This compares to earnings of $1.55 per share a year ago.
Top 3 Health Care Stocks That May Crash In August
As of Aug 14, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
